FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Lannett Dextroamphetamine Saccharate Recall

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulf…

Lannett Company Inc. · Seymour, IN

Risk level
Class II
Reported by FDA
Jul 8, 2026
Recall ID
D-0660-2026
Check your lot numberHow we source this data

Summary

Lannett recalled Dextroamphetamine Saccharate starting Jun 26, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0660-2026 on Jul 8, 2026. Reason: Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules. Status: Ongoing.

Why it was recalled

Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.

Product description

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.

Lot numbers, UPCs & expiration codes

Lot#: 25285401A, Exp. Date: 04/2027

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0660-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jun 26, 2026
FDA report date
Jul 8, 2026
Quantity
1392 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Lannett Company Inc.

Original FDA data

Every field from FDA enforcement report D-0660-2026, exactly as published.

Show all FDA fields
City
Seymour
State
IN
Status
Ongoing
Country
United States
Event ID
99319
Address
1101 C Ave W
Code information
Lot#: 25285401A, Exp. Date: 04/2027
Postal code
47274-3342
Report date
Jul 8, 2026
Product type
Drugs
Recall number
D-0660-2026
Classification
Class II
Recalling firm
Lannett Company Inc.
Product quantity
1392 bottles
Reason for recall
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.
Distribution pattern
US Nationwide.
Recall initiation date
Jun 26, 2026
Initial firm notification
Letter
Center classification date
Jul 2, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0660-2026, published Jul 8, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls